The Novo Nordisk Foundation is expanding and extending its Interdisciplinary Postdoctoral Fellowship Programme, thereby enabling ambitious researchers in the natural and technical sciences and life sciences to boost their careers with a research stay at one of several top international universities. Read more…
Copenhagen – The Novo Nordisk Foundation and the United Nations World Food Programme (WFP) have sealed a partnership to further advance WFP’s homegrown school feeding and smallholder farmer support programmes in Rwanda and Uganda. The Novo Nordisk Foundation has committed a US$4.1 million grant to improve health, nutrition, food security and incomes for marginalized and vulnerable […]
Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets Dusseldorf and Barcelona / Tel Aviv, October 6, 2022 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and Panaxia (TASE: PNAX), a global pharmaceutical company that develops, manufactures and markets advanced […]
Financing led by Brandon Capital, Forbion and Atlas Venture Aims to advance its lead ADC compound targeting a novel cancer antigen Serial biotech entrepreneur Bertrand Damour appointed as Chief Executive Officer Industry veteran Leigh Zawel appointed as Chief Scientific Officer Proprietary payload platform for development of novel ADCs London UK, 28 September 2022 – Pheon Therapeutics […]
Brighton, United Kingdom – 22 September 2022 – Destiny Pharma plc (AIM:DEST), a clinical stage biotechnology company focused on the development of novel medicines to prevent life threatening infections, today announces that it will host an R&D Update meeting for analysts and investors on Tuesday, 18 October 2022 at 1.00 pm BST / 8.00 am EST. Read more
